Search 
Saturday, July 05, 2008 ..:: Clinical Trials ::.. Register  Login
 Clinical Trials Minimize

 Print   
 Search Trials Minimize

 Print   
 Archives Minimize
Study Number:

Search


  
 Gastrointestinal Minimize
Category: Gastrointestinal Created: 11/27/2006 12:54 PM
Gastrointestinal

Colon (100962)
Sponsor: NIH (DC-PANVAC)

By Gastrointestinal on 7/5/2008 10:00 AM
A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected with PANVAC After Complete Resection of Hepatic Metastases of Colorectal Carcinoma

HIPAA Authorization
Informed Consent
Informed Consent - Observation
Protocol
More...

Esophagus (101169)
Sponsor: AstraZeneca (17103)

By Gastrointestinal on 7/5/2008 10:00 AM
Diagnosis of Esophageal Carcinomas by Plasma Mass Spectrometry

None Available
More...

Liver (101101)
Sponsor: MDS Nordion ()

By Gastrointestinal on 7/5/2008 10:00 AM
A Humanitarian Device Exemption Use Protocol of Theraspherem For Treatment of Unresectable Hepatocellular Carcinoma

None Available
More...

Pancreas (100717)
Sponsor: MUSC ()

By Gastrointestinal on 7/5/2008 10:00 AM
Molecular Detection of Pancreatic Cancer in Peripheral Blood

None Available
More...

Pancreas (100918)
Sponsor: MUSC (100918)

By Gastrointestinal on 7/5/2008 10:00 AM
Phase II Study of Neoadjuvant Gemcitabine/Oxaliplatin and Cetuximab Followed by Surgery or Concurrent External Beam Radiation With Capecitabine for Patients With Locally Advanced Unresectable Nonmetastatic Pancreatic Cancer

HIPAA Authorization - MUSC
Informed Consent - Intervention
Protocol
More...


 Print   
Copyright 2007 by Hollings Cancer Center   Terms Of Use  Privacy Statement